Parkside Financial Bank & Trust’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Parkside Financial Bank & Trust's RPRX Position: Q1 2026 in Review
Parkside Financial Bank & Trust increased its Royalty Pharma (RPRX) stake by 1% in Q1 2026, buying an estimated $307 and bringing the position to 674 shares worth $32.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1140.
Parkside Financial Bank & Trust first reported a position in RPRX in Q2 2021 and has held it in 20 quarters since. 590 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.
- Parkside Financial Bank & Trust held 674 shares of Royalty Pharma worth $32.3K as of Q1 2026.
- Parkside Financial Bank & Trust bought 7 Royalty Pharma shares in Q1 2026, an estimated $307.
- Royalty Pharma made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1140 holding.
- Parkside Financial Bank & Trust first reported a position in Royalty Pharma in Q2 2021 and has held it in 20 quarters since.
- 590 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.